1. Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
   Rajeev Nema et al, 2021, Front. Mol. Biosci. CrossRef
2. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
   Ramya Ambur Sankaranarayanan et al, 2022, Cancers CrossRef
3. PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
   Samyuktha Suresh et al, 2022, Cancers CrossRef
4. Pd2Spermine Complex Shows Cancer Selectivity and Efficacy to Inhibit Growth of Triple-Negative Breast Tumors in Mice
   Martin Vojtek et al, 2022, Biomedicines CrossRef
5. Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
   Amal Qattan et al, 2022, Biomedicines CrossRef
6. Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo
   Nanami Nakamura et al, 2022, IJMS CrossRef
7. A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients
   Luigi Coltelli et al, 2022, npj Breast Cancer CrossRef
8. Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse
   Oliver Hoffmann et al, 2022, J Cancer Res Clin Oncol CrossRef
9. PLAG co-treatment increases the anticancer effect of Adriamycin and cyclophosphamide in a triple-negative breast cancer xenograft mouse model
   Guen Tae Kim et al, 2022, Biochemical and Biophysical Research Communications CrossRef
10. Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration
    Akhil Behringer et al, 2022, Biomolecules CrossRef
11. Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer
    Anthony Ambesi et al, 2022, Cells CrossRef
12. Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective
    Sethu Parvathy Pillai Babu et al, 2022, Bulletin du Cancer CrossRef
13. Silencing of COL3A1 represses proliferation, migration, invasion, and immune escape of triple negative breast cancer cells via down-regulating PD-L1 expression.
    Fan Yang et al, 2022, Cell Biol Int CrossRef
14. The Effect of 1,2,4-Triazole-3-thiol Derivatives Bearing Hydrazone Moiety on Cancer Cell Migration and Growth of Melanoma, Breast, and Pancreatic Cancer Spheroids
    Aida Šermukšnytė et al, 2022, Pharmaceuticals CrossRef
15. In Vitro and In Vivo Relevant Antineoplastic Activity of Platinum(II) Complexes toward Triple-Negative MDA-MB-231 Breast Cancer Cell Line
    Leide Laura Figueiredo Maciel et al, 2022, Pharmaceutics CrossRef
16. Transcriptomic profiling of Indian breast cancer patients revealed subtype-specific mRNA and lncRNA signatures
    Meghana Manjunath et al, 2022, Front. Genet. CrossRef
17. Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer
    Yongxi Liang et al, 2022, Acta Pharmaceutica Sinica B CrossRef
18. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
    Eva Kudelova et al, 2022, IJMS CrossRef
19. Triple-negatives Mammakarzinom
    Hans-Peter Sinn et al, 2023, Pathologie CrossRef
20. Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review
    Lahanya Guha et al, 2022, CDM CrossRef
21. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review
    Boya Lu et al, 2023, Technol Cancer Res Treat CrossRef
22. Application of Targeted Autophagy in Triple Negative Breast Cancer
    敏 吕, 2023, ACM CrossRef
23. Acetylacetone and imidazole coordinated Re(I) tricarbonyl complexes: Experimental, DFT studies, and molecular docking approach
    Amanda-Lee E. Manicum et al, 2023, Chemical Physics Impact CrossRef
24. Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF
    Angelina Boccarelli et al, 2023, Pathology - Research and Practice CrossRef
25. The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response
    Paola Antonia Corsetto et al, 2023, IJMS CrossRef
26. Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging
    Juliana Pereira Lopes Gonçalves et al, 2023, IJMS CrossRef
27. null
    Md Abdus Subhan, 2023 CrossRef
28. Diagnostic value of ultrasound elastography in triple negative breast cancer: A meta-analysis
    Fei Wang et al, 2023 CrossRef
29. The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic Sulfatase-2 Gene in Breast Cancer Cells and Is Sensible Targets for Cancer Therapy
    Ping Yang et al, 2023, J Breast Cancer CrossRef
30. Camptothecin loaded casein nanosystem for tuning the therapeutic efficacy against highly metastatic triple-negative breast cancer cells
    Sajmina Khatun et al, 2023, Biomater. Sci. CrossRef
31. Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway
    Shenghan Gao et al, 2023, DDDT CrossRef
32. Based on immune checkpoint inhibitor to improve cancer treatment
    Yijin Chen, 2023, HSET CrossRef
33. Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines
    Sevda Jafari et al, 2023, Clin Transl Oncol CrossRef
34. Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
    Maria Grazia Ferraro et al, 2023, IJMS CrossRef
35. Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials
    Ibrahim Elmakaty et al, 2023, Cancer Cell Int CrossRef
36. Monoacylglycerol lipase inhibitor JJKK048 ameliorates ABCG2 transporter-mediated regorafenib resistance induced by hypoxia in triple negative breast cancer cells
    Elena Puris et al, 2023, Journal of Pharmaceutical Sciences CrossRef
37. null
    Ravinder Verma et al, 2023 CrossRef
38. Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer
    Lakshmi Kumari et al, 2023, Journal of Drug Targeting CrossRef
39. Design, synthesis, and biological evaluation of novel 4,4′-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer
    Guiping Gao et al, 2023, European Journal of Medicinal Chemistry CrossRef
40. Progress in the Understanding of Estrogen Receptor Alpha Signaling in Triple-Negative Breast Cancer: Reactivation of Silenced ER-α and Signaling through ER-α36
    Aya Y. Al-Kabariti et al, 2023 CrossRef
41. The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study
    Soheila Montazersaheb et al, 2023, Mol Biol Rep CrossRef
42. Preparation and anti-triple-negative breast cancer cell effect of a nanoparticle for the codelivery of paclitaxel and gemcitabine
    Fan Yang et al, 2023, Discover Nano CrossRef
43. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer
    Qiuhui Yang et al, 2023, J. Zhejiang Univ. Sci. B CrossRef
44. A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs
    Li Lv et al, 2023, Biomater Res CrossRef
45. Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion
    Xin Li et al, 2023, PPL CrossRef
46. Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells
    Yuki Ohya et al, 2024, Cells CrossRef
47. Anti-Cancer Activity and Mechanism of Resveratrol Against Triple-Negative Breast Cancer
    Xicai Zhang et al, 2024, j biobased mat bioenergy CrossRef